• OPEN AN ACCOUNT
Indian Indices
Sensex
81,028.02 1,718.01
( 2.17%)
Global Indices
Nasdaq
51,462.04 -82.02
(-0.16%)
Dow Jones
7,424.83 50.10
(0.68%)
Hang Seng
57,293.47 -3,784.43
(-6.20%)
Nikkei 225
10,662.59 -120.07
(-1.11%)
Forex
USD-INR
94.41 -0.18
(-0.19%)
EUR-INR
106.07 -0.23
(-0.22%)
GBP-INR
127.18 -0.23
(-0.18%)
JPY-INR
0.60 0.00
(-0.04%)

EQUITY - MARKET SCREENER

Divis Laboratories Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs
BSE Code
ISIN Demat
Book Value()
532488
INE361B01024
629.4942217
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
DIVISLAB
91.32
273565.37
EPS(TTM)
Face Value()
Div & Yield %
112.85
2
0.29
 

SML Mahindra gains after sales jumps 32% YoY in September
Oct 09,2026
Commercial vehicle production rose 19.83% year-on-year to 1,257 units in September 2026 from 1,049 units in September 2025.

However, exports declined 61.59% to 53 units in September 2026 from 138 units in September 2025.

SML Mahindra (formerly known as SML Isuzu) is primarily engaged in the business of the manufacture and sale of commercial vehicles and their parts.

The company’s standalone net profit declined 4.99% to Rs 63.62 crore in the quarter ended June 2026 as against Rs 66.96 crore during the previous quarter ended June 2025. Sales rose 13.20% to Rs 957.54 crore in the quarter ended June 2026 as against Rs 845.89 crore during the previous quarter ended June 2025.